Light retardance lower in NAION eyes

Article

Patients with optic disc swelling caused by nonarteritic anterior ischaemic optic neuropathy (NAION) have less light retardance compared with patients with optic disc swelling caused by papilloedema or optic neuritis.

Patients with optic disc swelling caused by nonarteritic anterior ischaemic optic neuropathy (NAION) have less light retardance compared with patients with optic disc swelling caused by papilloedema or optic neuritis.

For this cross-sectional study, researchers set out to compare retinal nerve fibre layer thickness (RNFLT) in patients with optic disc swelling of different etiologies, and included a total of 47 patients. Scanning laser polarimetry (SLP; enhanced corneal compensation) and spectral-domain optical coherence tomography (OCT) RNFLT measurements were done in 19 eyes with papilloedema, 10 eyes with optic neuritis, and 18 eyes with NAION.

They found no statistical differences on average OCT-RNFLT in papilloedema, optic neuritis, and NAION. The average SLP-RNFLT in patients with NAION was smaller compared with that measured in patients with papilloedema (P P = 0.02).

Comparisons of RNFLT in each retinal quadrant reveled no difference among the etiological groups upon OCT; upon SLP comparisons, however, the superior quadrant was found to be thinner in NAION patients compared with papilloedema or optic neuropathy patients (P P

Superior SLP-RNFLT in patients with NAION was smaller (P = 0.026). The ratio of average SLP-RNFLT to average OCT-RNFLT was smaller in patients with NAION compared with papilloedema (P = 0.001).

For more information on this study, click here.

Recent Videos
Quan Dong Nguyen, MD, MSc, of the Byers Eye Institute at Stanford University School of Medicine, discusses his presentation on Stargardt disease at the American Academy of Ophthalmology meeting
Abdelrahman Elhusseiny, MD, MSc, discusses his AAO presentation on risk of posterior capsular rupture in fellow-eyes cataract surgery
David Yorston, FRCS, FRCOphth, discusses his EURETINA keynote lecture
© 2024 MJH Life Sciences

All rights reserved.